The brome mosaic virus RNA3 intergenic replication enhancer folds to mimic a tRNA TpsiC-stem loop and is modified in vivo.
The genome of brome mosaic virus (BMV), a positive-strand RNA virus in the alphavirus-like superfamily, consists of three capped, messenger-sense RNAs. RNA1 and RNA2 encode viral replication proteins 1a and 2a, respectively. RNA3 encodes the 3a movement protein and the coat protein, which are essential for systemic infection in plants but dispensable for RNA3 replication in plants and yeast. A subset of the 250-base intergenic region (IGR), the replication enhancer (RE), contains all cis-acting signals necessary for a crucial, early template selection step, the 1a-dependent recruitment of RNA3 into replication. One of these signals is a motif matching the conserved box B sequence of RNA polymerase III transcripts. Using chemical modification with CMCT, kethoxal, DMS, DEPC, and lead, we probed the structure of the IGR in short, defined transcripts and in full-length RNA3 in vitro, in yeast extracts, and in whole yeast cells. Our results reveal a stable, unbranched secondary structure that is not dependent on the surrounding ORF sequences or on host factors within the cell. Functional 5' and 3' deletions that defined the minimal RE in earlier deletion studies map to the end of a common helical segment. The box B motif is presented as a hairpin loop of 7 nt closed by G:C base pairs in perfect analogy to the TpsiC-stem loop in tRNA(Asp). An adjacent U-rich internal loop, a short helix, and another pyrimidine-rich loop were significantly protected from base modifications. This same arrangement is conserved between BMV and cucumoviruses CMV, TAV, and PSV. In the BMV box B loop sequence, uridines corresponding to tRNA positions T54 and psi55 were found to be modified in yeast and plants to 5mU and pseudouridine. Together with the aminoacylated viral 3'-end, this is thus the second RNA replication signal within BMV where the virus has evolved a tRNA structural mimicry to a degree that renders it a substrate for classical tRNA modification reactions in vivo.
Baumstark
T
T
Institute for Molecular Virology and Howard Hughes Medical Institute, University of Wisconsin-Madison, 53706, USA.
Ahlquist
P
P
D000447:Aldehydes; D001483:Base Sequence; D019177:Bromoviridae / Q000235:genetics; D017795:Bromovirus / Q000235:genetics*; D002074:Butanones; D003028:CME-Carbodiimide / Q000031:analogs & derivatives*; D002213:Capsid / Q000235:genetics*; D036022:Capsid Proteins; D021901:DNA, Intergenic; D004742:Enhancer Elements, Genetic; D008969:Molecular Sequence Data; D009690:Nucleic Acid Conformation; D010767:Phosphorylcholine / Q000031:analogs & derivatives*; D053830:Plant Viral Movement Proteins; D011743:Pyrimidines; D012343:RNA, Transfer / Q000737:chemistry*; D012367:RNA, Viral / Q000096:biosynthesis / Q000737:chemistry*; D014764:Viral Proteins / Q000235:genetics*
D000447:Aldehydes; D002074:Butanones; D036022:Capsid Proteins; D021901:DNA, Intergenic; C437127:O,O-diethylphosphorylcholine iodide; D053830:Plant Viral Movement Proteins; D011743:Pyrimidines; D012367:RNA, Viral; D014764:Viral Proteins; C430231:coat protein, Brome mosaic virus; D010767:Phosphorylcholine; C060331:1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide; D003028:CME-Carbodiimide; D012343:RNA, Transfer; C005135:kethoxal; C030986:pyrimidine